This trial will study the immune responses of different age groups before and after they receive the seasonal influenza vaccine.
1 Primary · 7 Secondary · Reporting Duration: 7 years
Side Effects for
Awards & Highlights
1 Treatment Group
1 of 1
700 Total Participants · 1 Treatment Group
Primary Treatment: Seasonal influenza vaccine · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment currently open for this trial?
"Affirmative. Clinicaltrials.gov provides evidence that this experiment, which was initially posted on October 7th 2021, is presently recruiting patients. Approximately 700 individuals need to be enrolled at a single research centre." - Anonymous Online Contributor
Has the FDA endorsed Seasonal influenza vaccine?
"As this is a Phase 4 trial and Seasonal influenza vaccine has already been approved, the treatment's safety rating was established as a 3." - Anonymous Online Contributor
How many individuals is this research endeavor following?
"Affirmative. According to clinicaltrials.gov, this research study is presently recruiting volunteers and the trial was initially posted on October 7th 2021. Last updated on November 17th 2022, it aims to enrol 700 individuals at a single medical facility." - Anonymous Online Contributor